![Anthony P. Jansz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony P. Jansz
Direttore/Membro del Consiglio presso The Medical Finance Co.
Profilo
Anthony P.
Jansz is currently a Director at The Medical Finance Co. Prior to this, he was a Director at EnteroMedics, Inc. from 2015 to 2016.
He was also a Managing Director at The Carlyle Group, Inc. from 2005 to 2005.
Additionally, he served as Chairman at The Australian Institute of Weight Control in 2011.
Posizioni attive di Anthony P. Jansz
Società | Posizione | Inizio |
---|---|---|
The Medical Finance Co. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Anthony P. Jansz
Società | Posizione | Fine |
---|---|---|
EnteroMedics, Inc.
![]() EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Direttore/Membro del Consiglio | 12/08/2016 |
The Australian Institute of Weight Control | Presidente | 01/03/2011 |
THE CARLYLE GROUP INC. | Corporate Officer/Principal | 01/01/2005 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
THE CARLYLE GROUP INC. | Finance |
Aziende private | 3 |
---|---|
EnteroMedics, Inc.
![]() EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Health Technology |
The Australian Institute of Weight Control | |
The Medical Finance Co. |
- Borsa valori
- Insiders
- Anthony P. Jansz